Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.

Feature | Udi Nussinovitch M.D., Ph.D.

What is New in Cardiology? A Review of All Major Emerging Technologies for Heart Diseases

This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail ...

October 09, 2020

Videos | Radial Access

VIDEO: Radial Access Recovery Lounges Aid Patient Satisfaction and Comfort Post-PCI

Jordan G. Safirstein, M.D., FACC, FSCAI, director of transradial catheterization for Atlantic Health System’s Morristown ...

October 07, 2020

Videos | Coronavirus (COVID-19)

VIDEO: ECMO Support Effective in Sickest COVID-19 Patients

Ryan Barbaro, M.D., clinical assistant professor, pediatric critical care medicine, University of Michigan, and chair of ...

October 06, 2020

Chest X-ray of a congestive heart failure patient, showing fluid in the lower portions of the lungs and an enlarged heart. Getty Images

News | Heart Failure

ACC and Novartis Collaborate to Optimize Heart Failure Care With TRANSFORM Study

October 5, 2020 — The American College of Cardiology (ACC) says heart failure (HF) is a cardiovascular epidemic. In ...

October 05, 2020

News | VIVA

The Latest Vascular Interventional Clinical Data Presented at VIVA 2020

October 5, 2020 — The Vascular Interventional Advances (VIVA) virtual conference will feature 10 late-breaking clinical ...

October 05, 2020

Webinar | Cardiovascular Information Systems (CVIS)

WEBINAR: Intelligently Efficient Adult Echo Structured Reporting

The dynamics of our world are changing rapidly. Cardiologists are being challenged to complete documentation in an ...

October 05, 2020

Very ill COVID-19 patients have a high rate of in-hospital sudden cardiac arrest and a very low survival rate.

Feature | Coronavirus (COVID-19)

Cardiac Arrest With Poor Survival Common in Sickest COVID-19 Patients

October 2, 2020 — Even when a sudden cardiac arrest happens inside a top hospital, where a code blue team is readily ...

October 02, 2020

The Cardiac Dimensions Carillon Mitral Contour System, a transcatheter device used to treat functional mitral regurgitation (FMR) in patients with heart failure.

News | Heart Valve Technology

Cardiac Dimensions Announces $17.5 Million in Financing to Accelerate Sales Expansion of The Carillon Mitral Contour System

October 2, 2020 — Cardiac Dimensions announced the company has closed a $17.5 million Series C financing that will be ...

October 02, 2020

Videos | Left Atrial Appendage (LAA) Occluders

VIDEO: Overview of Left Atrial Appendage (LAA) Closure Technology and New Innovations

Horst Sievert, M.D., is the director of the Cardiovascular Center Frankfurt, and associate professor of internal ...

October 02, 2020

News | Coronavirus (COVID-19)

ECMO Support Found Effective in Sickest of COVID-19 Patients

September 29, 2020 – Extracorporeal membrane oxygenation (ECMO) support saved lives in past epidemics of lung-damaging ...

September 29, 2020

Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in Europe. This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original Acurate neo platform. Compared to the previous generation device, the Acurate neo2 valve system also has an expanded indication for patients with aortic stenosis. #TAVR #TAVI

News | Heart Valve Technology

Boston Scientific Launches Acurate neo2 Transcatheter Aortic Valve System in Europe

September 29, 2020 — Boston Scientific launched the Acurate neo2 transcatheter aortic valve replacement (TAVR) system in ...

September 29, 2020

The VitalPatch RTM biosensor is being used in the TELESTAR-TAVR clinical study (Deployment of Telemedicine for Symptom Tracking And Decrease Readmission Rate in TAVR Patients). It will evaluate patients who undergo a transcatheter aortic valve replacement (TAVR) and monitor them following the procedure utilizing the latest technology from VitalConnect, VistaSolution LIVE.

News | Wearables

VitalConnect Announces Initiation of TELESTAR-TAVR Clinical Study

September 25, 2020 — Remote and in-hospital wearable biosensor technology company VitalConnect Inc. has started the ...

September 25, 2020

The Optimizer Smart System is a pacemaker-like device that improves heart function and reduces debilitating symptoms associated with the disease, including fatigue and shortness of breath.

News | Heart Failure

Allegheny General Hospital Cardiologists First in the Region to Use Novel Implantable Device to Treat Heart Failure

September 23, 2020 – A team of cardiologists at Allegheny General Hospital (AGH), part of Allegheny Health Network (AHN) ...

September 23, 2020

Videos | Artificial Intelligence

VIDEO: Artificial Intelligence May Improve Cath Lab Interventions

Nick West, M.D., chief medical officer for Abbott, explains the details from a survey of 1,400 patients, physicians and ...

September 21, 2020

TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT

Feature | TCT

TCT 2020 Late-breaking Study Presentations Announced

October 15, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular ...

October 15, 2020